CN116536226A - 产苏氨酸工程菌的构建方法 - Google Patents
产苏氨酸工程菌的构建方法 Download PDFInfo
- Publication number
- CN116536226A CN116536226A CN202210096134.2A CN202210096134A CN116536226A CN 116536226 A CN116536226 A CN 116536226A CN 202210096134 A CN202210096134 A CN 202210096134A CN 116536226 A CN116536226 A CN 116536226A
- Authority
- CN
- China
- Prior art keywords
- threonine
- microorganism
- enzyme
- formyl
- enhanced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004473 Threonine Substances 0.000 title claims abstract description 87
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 title claims abstract description 85
- 238000010276 construction Methods 0.000 title claims abstract description 27
- 241000894006 Bacteria Species 0.000 title claims abstract description 14
- 108010064711 Homoserine dehydrogenase Proteins 0.000 claims abstract description 57
- TYULBXBFDQOOFP-UHFFFAOYSA-N 2-hydroxy-4-oxobutane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(C=O)C(O)=O)C(O)=O TYULBXBFDQOOFP-UHFFFAOYSA-N 0.000 claims abstract description 54
- 238000004519 manufacturing process Methods 0.000 claims abstract description 33
- 230000014509 gene expression Effects 0.000 claims abstract description 31
- 108010055400 Aspartate kinase Proteins 0.000 claims abstract description 29
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 21
- 108010084634 NADP phosphatase Proteins 0.000 claims abstract description 20
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 20
- 102000006843 Threonine synthase Human genes 0.000 claims abstract description 19
- 108010022394 Threonine synthase Proteins 0.000 claims abstract description 19
- 230000037361 pathway Effects 0.000 claims abstract description 17
- 102000004625 Aspartate Aminotransferases Human genes 0.000 claims abstract description 12
- 108010003415 Aspartate Aminotransferases Proteins 0.000 claims abstract description 12
- 102100030892 Fructose-1,6-bisphosphatase isozyme 2 Human genes 0.000 claims abstract description 12
- 101001063910 Homo sapiens Fructose-1,6-bisphosphatase isozyme 2 Proteins 0.000 claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 61
- 244000005700 microbiome Species 0.000 claims description 39
- 102000004190 Enzymes Human genes 0.000 claims description 34
- 108090000790 Enzymes Proteins 0.000 claims description 34
- 230000000694 effects Effects 0.000 claims description 34
- 241000186226 Corynebacterium glutamicum Species 0.000 claims description 29
- 239000013612 plasmid Substances 0.000 claims description 29
- 102000005532 NAD kinase Human genes 0.000 claims description 19
- 210000000349 chromosome Anatomy 0.000 claims description 17
- 238000000034 method Methods 0.000 claims description 14
- 150000001413 amino acids Chemical group 0.000 claims description 12
- 239000002773 nucleotide Substances 0.000 claims description 11
- 125000003729 nucleotide group Chemical group 0.000 claims description 11
- 230000002708 enhancing effect Effects 0.000 claims description 10
- 230000004048 modification Effects 0.000 claims description 6
- 238000012986 modification Methods 0.000 claims description 6
- 230000001965 increasing effect Effects 0.000 claims description 5
- 241000186031 Corynebacteriaceae Species 0.000 claims description 4
- 229940024606 amino acid Drugs 0.000 claims description 4
- 230000009467 reduction Effects 0.000 claims description 3
- 230000003313 weakening effect Effects 0.000 claims description 3
- 230000002238 attenuated effect Effects 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 238000002744 homologous recombination Methods 0.000 claims description 2
- 230000006801 homologous recombination Effects 0.000 claims description 2
- 238000001727 in vivo Methods 0.000 claims description 2
- 238000002703 mutagenesis Methods 0.000 claims description 2
- 231100000350 mutagenesis Toxicity 0.000 claims description 2
- 238000002741 site-directed mutagenesis Methods 0.000 claims description 2
- 241000186216 Corynebacterium Species 0.000 abstract description 8
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 102100023515 NAD kinase Human genes 0.000 abstract 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 78
- 229960002898 threonine Drugs 0.000 description 71
- 239000002609 medium Substances 0.000 description 39
- 210000004027 cell Anatomy 0.000 description 27
- 238000012408 PCR amplification Methods 0.000 description 25
- 229930006000 Sucrose Natural products 0.000 description 18
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 18
- 210000004556 brain Anatomy 0.000 description 18
- 238000001802 infusion Methods 0.000 description 18
- 239000005720 sucrose Substances 0.000 description 18
- 239000012634 fragment Substances 0.000 description 14
- 238000000855 fermentation Methods 0.000 description 12
- 230000004151 fermentation Effects 0.000 description 12
- 230000002779 inactivation Effects 0.000 description 12
- 241001485655 Corynebacterium glutamicum ATCC 13032 Species 0.000 description 11
- 239000000243 solution Substances 0.000 description 10
- 238000004520 electroporation Methods 0.000 description 9
- 229930027917 kanamycin Natural products 0.000 description 9
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 9
- 229960000318 kanamycin Drugs 0.000 description 9
- 229930182823 kanamycin A Natural products 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 230000006798 recombination Effects 0.000 description 9
- 238000005215 recombination Methods 0.000 description 9
- 238000012163 sequencing technique Methods 0.000 description 9
- 238000013207 serial dilution Methods 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 238000010367 cloning Methods 0.000 description 8
- 230000004927 fusion Effects 0.000 description 8
- 230000000415 inactivating effect Effects 0.000 description 7
- 238000011144 upstream manufacturing Methods 0.000 description 7
- 101100409478 Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) prpC1 gene Proteins 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 235000013339 cereals Nutrition 0.000 description 6
- 230000001131 transforming effect Effects 0.000 description 6
- 101150035025 lysC gene Proteins 0.000 description 5
- 101100096533 Drosophila melanogaster SelD gene Proteins 0.000 description 4
- 102000012195 Fructose-1,6-bisphosphatases Human genes 0.000 description 4
- 108010017464 Fructose-Bisphosphatase Proteins 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 101150000850 thrC gene Proteins 0.000 description 4
- 101100337176 Escherichia coli (strain K12) gltB gene Proteins 0.000 description 3
- 101100505027 Escherichia coli (strain K12) gltD gene Proteins 0.000 description 3
- 101100459576 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) ppnK gene Proteins 0.000 description 3
- 101100057034 Talaromyces wortmannii astB gene Proteins 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 101150070145 aspB gene Proteins 0.000 description 3
- 101150049887 cspB gene Proteins 0.000 description 3
- 101150041068 cspJ gene Proteins 0.000 description 3
- 101150010904 cspLB gene Proteins 0.000 description 3
- 101150100742 dapL gene Proteins 0.000 description 3
- 101150063051 hom gene Proteins 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 238000011426 transformation method Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- -1 aspartyl Chemical group 0.000 description 2
- 235000010633 broth Nutrition 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 101150097303 glyA gene Proteins 0.000 description 2
- 101150079604 glyA1 gene Proteins 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- VUUZLZXGRRDWBP-AAZKHNGSSA-N (2s,3r)-2-azanyl-3-oxidanyl-butanoic acid Chemical compound C[C@@H](O)[C@H](N)C(O)=O.C[C@@H](O)[C@H](N)C(O)=O VUUZLZXGRRDWBP-AAZKHNGSSA-N 0.000 description 1
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 244000003416 Asparagus officinalis Species 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 241000424760 Corynebacterium crenatum Species 0.000 description 1
- XPYBSIWDXQFNMH-UHFFFAOYSA-N D-fructose 1,6-bisphosphate Natural products OP(=O)(O)OCC(O)C(O)C(O)C(=O)COP(O)(O)=O XPYBSIWDXQFNMH-UHFFFAOYSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 102000002667 Glycine hydroxymethyltransferase Human genes 0.000 description 1
- 108010043428 Glycine hydroxymethyltransferase Proteins 0.000 description 1
- 108020005350 Initiator Codon Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 102100033451 Thyroid hormone receptor beta Human genes 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- RNBGYGVWRKECFJ-ZXXMMSQZSA-N alpha-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ZXXMMSQZSA-N 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229940085298 biotin 10 mg Drugs 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 235000012182 cereal bars Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 241000186254 coryneform bacterium Species 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- RNBGYGVWRKECFJ-UHFFFAOYSA-N fructose-1,6-phosphate Natural products OC1C(O)C(O)(COP(O)(O)=O)OC1COP(O)(O)=O RNBGYGVWRKECFJ-UHFFFAOYSA-N 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 101150024374 glpX gene Proteins 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 108010071598 homoserine kinase Proteins 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000004952 protein activity Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 101150072448 thrB gene Proteins 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/77—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1217—Phosphotransferases with a carboxyl group as acceptor (2.7.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01003—Homoserine dehydrogenase (1.1.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/03—Acyl groups converted into alkyl on transfer (2.3.3)
- C12Y203/03005—2-Methylcitrate synthase (2.3.3.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y206/00—Transferases transferring nitrogenous groups (2.6)
- C12Y206/01—Transaminases (2.6.1)
- C12Y206/01001—Aspartate transaminase (2.6.1.1), i.e. aspartate-aminotransferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
- C12Y207/01023—NAD+ kinase (2.7.1.23)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/02—Phosphotransferases with a carboxy group as acceptor (2.7.2)
- C12Y207/02004—Aspartate kinase (2.7.2.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03011—Fructose-bisphosphatase (3.1.3.11)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/03—Carbon-oxygen lyases (4.2) acting on phosphates (4.2.3)
- C12Y402/03001—Threonine synthase (4.2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/15—Corynebacterium
Abstract
本发明提供一种产苏氨酸工程菌的构建方法。本发明将2‑甲酰‑柠檬酸合酶1失活菌株(棒杆菌)应用于苏氨酸生产,其苏氨酸的产量较未改造菌株可提高42%左右。进一步将其与苏氨酸合成路径中的天冬氨酸氨基转移酶、天冬氨酸激酶、高丝氨酸脱氢酶、苏氨酸合酶、NAD激酶、果糖‑1,6‑二磷酸酶2等中的至少一个表达强化相组合时,苏氨酸的产量均有所提升。为大规模生产苏氨酸提供了新途径,具有较高的应用价值。
Description
技术领域
本发明属于微生物工程技术领域,具体地说,涉及一种产苏氨酸工程菌的构建方法。
背景技术
L-苏氨酸(L-Threonin),化学名称β-羟基-α-氨基丁酸,分子式C4H9NO3,相对分子质量119.12。L-苏氨酸是一种必需的氨基酸,苏氨酸主要用于医药、化学试剂、食品强化剂、饲料添加剂等方面。
谷氨酸棒杆菌中,由草酰乙酸生成苏氨酸需五步催化反应,分别为天冬氨酸激酶(lysC编码)、天冬氨酸半醛脱氢酶(asd编码)、高丝氨酸脱氢酶(hom编码)、高丝氨酸激酶(thrB)及苏氨酸合酶(thrC)编码。Hermann Sahm等人一直致力于高产苏氨酸的谷棒菌株的开发,并取得一定突破,获得了抗反馈抑制的hom基因(Reinscheid D J,Eikmanns B J,Sahm H.Analysis of a Corynebacterium glutamicum hom gene coding for afeedback-resistant homoserine dehydrogenase.[J].Journal of Bacteriology,1991,173(10):3228-3230)、lysC基因(Eikmanns B J,Eggeling L,Sahm H.Molecular aspectsof lysine,threonine,and isoleucine biosynthesis in Corynebacteriumglutamicum.[J].Antonie Van Leeuwenhoek,1993,64(2):145-163)。继Hermann Sahm之后,Lothar Eggling在该领域进行了进一步探索,弱化苏氨酸利用途径中的编码基因glyA,同时过表达苏氨酸外运蛋白ThrE,使得苏氨酸的产量由49mM提高到67mM(Simic P,WilluhnJ,Sahm H,et al.Identification of glyA(Encoding SerineHydroxymethyltransferase)and Its Use Together with the Exporter ThrE ToIncrease l-Threonine Accumulation by Corynebacterium glutamicum[J].Appliedand Environmental Microbiology,2002,68(7):3321-3327)。
目前利用谷氨酸棒状杆菌生产苏氨酸的报道主要集中在其合成路径中,关于前体供应等方面的报道较少。且现有报道仅对苏氨酸合成路径做了初步研究,尚未形成系统。
发明内容
本发明的目的是通过失活2-甲酰-柠檬酸合酶1使菌株生产苏氨酸的能力得到提升,从而提供一种产苏氨酸(L-苏氨酸)工程菌的构建方法。
为了实现本发明目的,第一方面,本发明提供一种修饰的棒状杆菌属微生物,所述微生物相比于未修饰的微生物,其2-甲酰-柠檬酸合酶1的活性降低或丧失,且所述微生物相比于未修饰的微生物具有增强的苏氨酸生产能力。优选地,2-甲酰-柠檬酸合酶1在NCBI上的参考序列编号为WP_011013823.1,或与其相似性为90%的氨基酸序列。
进一步地,所述微生物体内2-甲酰-柠檬酸合酶1的活性降低或丧失是通过降低编码2-甲酰-柠檬酸合酶1基因的表达或敲除内源的编码2-甲酰-柠檬酸合酶1的基因来实现的。
可以采用诱变、定点突变或同源重组等方法来降低编码2-甲酰-柠檬酸合酶1基因的表达或敲除内源的编码2-甲酰-柠檬酸合酶1的基因。
进一步地,所述微生物与未修饰的微生物相比,其体内苏氨酸合成途径相关的酶的活性增强;
其中,所述与苏氨酸合成途径相关的酶选自天冬氨酸氨基转移酶、天冬氨酸激酶、高丝氨酸脱氢酶、苏氨酸合酶、NAD激酶、果糖-1,6-二磷酸酶2中的至少一种;优选地,它们在NCBI上的参考序列编号分别为WP_011013497.1、WP_003855724.1、WP_003854900.1、WP_011014964.1、NP_600631.1、WP_003856830.1,或与上述参考序列相似度为90%的氨基酸序列。
优选地,所述微生物为如下①~⑤中的任一种:
①2-甲酰-柠檬酸合酶1活性降低或丧失且天冬氨酸激酶和/或高丝氨酸脱氢酶活性增强的微生物;
②2-甲酰-柠檬酸合酶1活性降低或丧失且天冬氨酸激酶、高丝氨酸脱氢酶和/或苏氨酸合酶活性增强的微生物;
③2-甲酰-柠檬酸合酶1活性降低或丧失且天冬氨酸激酶、高丝氨酸脱氢酶和/或NAD激酶活性增强的微生物;
④2-甲酰-柠檬酸合酶1活性降低或丧失且天冬氨酸激酶、高丝氨酸脱氢酶、NAD激酶和/或果糖-1,6-二磷酸酶2活性增强的微生物;
⑤2-甲酰-柠檬酸合酶1活性降低或丧失且天冬氨酸氨基转移酶、天冬氨酸激酶、高丝氨酸脱氢酶、苏氨酸合酶、NAD激酶和果糖-1,6-二磷酸酶2活性增强的微生物。
所述微生物体内苏氨酸合成途径相关的酶的活性的增强是由选自以下1)~6),或任选的组合实现的:
1)通过导入具有所述酶的编码基因的质粒而增强;
2)通过增加染色体上所述酶的编码基因的拷贝数而增强;
3)通过改变染色体上所述酶的编码基因的启动子序列而增强;
4)通过将强启动子与所述酶的编码基因可操作地连接而增强;
5)通过对酶的氨基酸序列进行改变而增强;
6)通过对编码酶的核苷酸序列进行改变而增强。
优选地,本发明所述棒杆菌为谷氨酸棒状杆菌(Corynebacterium glutamicum),谷氨酸棒状杆菌包括ATCC13032、ATCC13870、ATCC13869、ATCC21799、ATCC21831、ATCC14067、ATCC13287等(参见NCBI Corunebacterium glutamicum进化树https://www.ncbi.nlm.nih.gov/genome/469),更优选谷氨酸棒状杆菌ATCC 13032。
第二方面,本发明提供产苏氨酸工程菌的构建方法,所述方法包括:
A、弱化具有氨基酸生产能力的棒杆菌中编码2-甲酰-柠檬酸合酶1的基因,获得基因弱化菌株;所述弱化包括敲除或降低2-甲酰-柠檬酸合酶1编码基因的表达;和/或
B、增强步骤A基因弱化菌株中与苏氨酸合成途径相关的酶,获得酶活增强菌株;
所述增强的途径选自以下1)~5),或任选的组合:
1)通过导入具有所述酶的编码基因的质粒而增强;
2)通过增加染色体上所述酶的编码基因的拷贝数而增强;
3)通过改变染色体上所述酶的编码基因的启动子序列而增强;
4)通过将强启动子与所述酶的编码基因可操作地连接而增强;
5)通过对酶的氨基酸序列进行改变而增强。
第三方面,本发明提供一种生产苏氨酸的方法,所述方法包括如下步骤:
a)培养所述修饰的棒状杆菌属微生物,以获得所述微生物的培养物;
b)从步骤a)中获得的所述培养物中收集所产生的苏氨酸。
第四方面,本发明提供编码2-甲酰-柠檬酸合酶1的基因的敲除或降低表达在苏氨酸发酵生产或提高苏氨酸发酵产量中的应用。
进一步地,通过失活具有氨基酸生产能力的棒杆菌(Corynebacterium)中的2-甲酰-柠檬酸合酶1来提高苏氨酸的发酵产量。
优选地,本发明所述棒杆菌为谷氨酸棒状杆菌(Corynebacterium glutamicum),谷氨酸棒状杆菌包括ATCC13032、ATCC13870、ATCC13869、ATCC21799、ATCC21831、ATCC14067、ATCC13287等(参见NCBI Corunebacterium glutamicum进化树https://www.ncbi.nlm.nih.gov/genome/469),更优选谷氨酸棒状杆菌ATCC 13032。
第五方面,本发明提供所述修饰的棒状杆菌属微生物或按照上述方法构建得到的产苏氨酸工程菌在苏氨酸发酵生产或提高苏氨酸发酵产量中的应用。
上述有关菌株的改造方法包括基因的强化和弱化等均为本领域技术人员可知的改造方式,参见满在伟.高产L-精氨酸钝齿棒杆菌的系统途径工程改造[D].江南大学,2016;崔毅.代谢工程改造谷氨酸棒杆菌生产L--亮氨酸[D].天津科技大学.;徐国栋.L-异亮氨酸生产菌株的构建及发酵条件优化.天津科技大学,2015.
借由上述技术方案,本发明至少具有下列优点及有益效果:
本发明通过失活2-甲酰-柠檬酸合酶1,增强苏氨酸合成前体草酰乙酸的供应,提高菌株生产苏氨酸的能力。本发明将2-甲酰-柠檬酸合酶1失活菌株(棒杆菌,如谷氨酸棒状杆菌)应用于苏氨酸生产,其苏氨酸的产量较未改造菌株可提高60%左右。进一步将其与苏氨酸合成路径中的天冬氨酸氨基转移酶、天冬氨酸激酶、高丝氨酸脱氢酶、苏氨酸合酶、NAD激酶、果糖-1,6-二磷酸酶2等中的至少一个表达强化相组合时,苏氨酸的产量均有所提升。为大规模生产苏氨酸提供了新途径,具有较高的应用价值。
具体实施方式
本发明通过失活2-甲酰-柠檬酸合酶1提高了菌株(如谷氨酸棒状杆菌)生产苏氨酸的产量。
2-甲酰-柠檬酸合酶1与苏氨酸合成路径不直接相关,且目前尚未由2-甲酰-柠檬酸合酶1失活可提高苏氨酸下游产物的相关报道。为此,本发明先以谷氨酸棒状杆菌ATCC13032为出发菌,构建2-甲酰-柠檬酸合酶1失活菌株,获得的改造菌苏氨酸产量较低为0.2g/L,与预期是不符,推测其苏氨酸合成受苏氨酸合成路径中的天冬氨酸激酶和高丝氨酸脱氢酶受到胞内苏氨酸浓度的严格调控。因此,改造菌株生产苏氨酸,首先打通其合成路径,主要包括天冬氨酸激酶、高丝氨酸脱氢酶的解调控及表达强化,获得改造菌SMCT077使得菌株具备初步的苏氨酸合成能力,其苏氨酸产量为2.4g/L,进一步的失活prpC1,苏氨酸的产量达到3.3g/L。由此可知虽然2-甲酰-柠檬酸合酶1的失活有利于苏氨酸的生产,当其与苏氨酸生产菌株中的其他与苏氨酸合成相关的位点相结合时,其苏氨酸的生产能力会进一步提升。
为了进一步验证苏氨酸产量的提升是由于2-甲酰-柠檬酸合酶1失活造成的,在对SMCT077菌株进一步强化表达天冬氨酸氨基转移酶、苏氨酸合酶、NAD激酶以及果糖-1,6-二磷酸酶中至少一个酶的菌株进行prpC1失活获得的一系列菌株,其苏氨酸的产量均有所提高,转化率较未改造菌株提高42%。
改造过程中的表达强化包括启动子的替换,核糖体结合位点的改变、拷贝数的增加、氨基酸序列的改变造成活性增加及质粒过表达等手段,失活包括表达活性的降低及无活性,且以上手段均为本领域研究人员公知手段。以上手段无法通过举例而穷尽,具体实施例中仅以启动子强化作为代表进行说明;另外本发明仅列出部分改造的组合,有关上述位点的所有组合均可提高苏氨酸的产量,本文仅举例说明,并未以穷尽的方式全部说明。
本发明采用如下技术方案:
本发明的技术方案之一,提供一种利用2-甲酰-柠檬酸合酶1失活的棒杆菌生产苏氨酸的方法。
本发明的技术方案之二,提供一种利用2-甲酰-柠檬酸合酶1失活及天冬氨酸氨基转移酶、天冬氨酸激酶、高丝氨酸脱氢酶、苏氨酸合酶、NAD激酶、果糖-1,6-二磷酸酶2至少一个表达强化生产苏氨酸的方法。
本发明的技术方案之三,提供一种利用天冬氨酸激酶和高丝氨酸脱氢酶解调控及表达强化和2-甲酰-柠檬酸合酶1失活生产苏氨酸的方法。
本发明的技术方案之四,提供一种利用2-甲酰-柠檬酸合酶1失活和天冬氨酸激酶、高丝氨酸脱氢酶、苏氨酸合酶表达强化生产苏氨酸的方法。
本发明的技术方案之五,提供一种利用2-甲酰-柠檬酸合酶1失活和天冬氨酸激酶、高丝氨酸脱氢酶、NAD激酶表达强化生产苏氨酸的方法。
本发明的技术方案之六,提供一种利用2-甲酰-柠檬酸合酶1失活和天冬氨酸激酶、高丝氨酸脱氢酶、NAD激酶、果糖-1,6-二磷酸酶2表达强化生产苏氨酸的方法。
本发明的技术方案之七,提供一种利用2-甲酰-柠檬酸合酶1失活及天冬氨酸氨基转移酶、天冬氨酸激酶、高丝氨酸脱氢酶、苏氨酸合酶、NAD激酶、果糖-1,6-二磷酸酶表达强化生产苏氨酸的方法。
上述菌株为棒杆菌,优选谷氨酸棒状杆菌,最优选谷氨酸棒状杆菌ATCC 13032。
本发明涉及的蛋白及其编码基因如下:
2-甲酰-柠檬酸合酶1,编码基因名称prpC1,NCBI编号:cg0798、Cgl0696、NCgl0666。
天冬氨酸氨基转移酶,编码基因名称aspB,NCBI编号:cg0294、Cgl0240、NCgl0237。
天冬氨酸激酶,编码基因名称lysC,NCBI编号:cg0306、Cgl0251、NCgl0247。
高丝氨酸脱氢酶,编码基因名称hom,NCBI编号:cg1337、Cgl1183、NCgl1136。
苏氨酸合酶,编码基因名称thrC,NCBI编号:cg2437、Cgl2220、NCgl2139。
NAD激酶,编码基因名称ppnK,NCBI编号:cg1601、Cgl1413、NCgl1358。
果糖-1,6-二磷酸酶2,编码基因名称fbp/glpX,NCBI编号:cg1157、Cgl1019、Ncgl0976。
以下实施例用于说明本发明,但不用来限制本发明的范围。若未特别指明,实施例均按照常规实验条件,如Sambrook等分子克隆实验手册(Sambrook J&Russell DW,Molecular Cloning:a Laboratory Manual,2001),或按照制造厂商说明书建议的条件。
以下实施例中使用的实验材料如下:
以下实施例中涉及的实验方法如下:PCR扩增体系如下:
PCR扩增程序如下:
菌株改造方法:
1、无缝组装反应程序:参照ClonExpress MultiS One Step Cloning Kit说明书。
2、转化方法:参照Trans1-T1 Phage Resistant Chemically Competent Cell说明书。
3、感受态细胞的制备:参照C.glutamicum Handbook,Charpter 23。
实施例1菌株基因组改造质粒的构建
1、天冬氨酸激酶表达强化质粒pK18mobsacB-Psod-lysCg1a-T311I的构建
以谷氨酸棒状杆菌ATCC 13032基因组为模板,以P21/P22引物对进行PCR扩增得到上游同源臂up,以P23/P24引物对进行PCR扩增得到启动子片段Psod,以P25/P26引物对进行PCR扩增得到lysCg1a-T311I,以P27/P28引物对进行PCR扩增得到下游同源臂dn。以P21/P24引物对以up、Psod为模板进行融合PCR,获得片段up-Psod。以P21/P28引物对以up-Psod、lysCg1a-T311I、dn为模板进行融合PCR获得全长片段up-Psod-lysCg1a-T311I-dn。pK18mobsacB用BamHI/HindIII酶切。两者用无缝克隆试剂盒进行组装,转化Trans1 T1感受态细胞,获得重组质粒pK18mobsacB-Psod-lysCg1a-T311I。
其中,g1a表示lysC基因(lysC野生型基因序列见SEQ ID NO:1)起始密码子的第1位碱基由g突变为a,T311I表示lysC基因编码的天冬氨酸激酶的第311为氨基酸由T突变为I。
2、高丝氨酸脱氢酶表达强化质粒pK18mobsacB-PcspB-homG378E的构建
以谷氨酸棒状杆菌ATCC 13032基因组为模板,以P29/P30引物对进行PCR扩增得到上游同源臂up,以ATCC14067基因组为模板以P31/P32引物对进行PCR扩增得到启动子片段PcspB,以ATCC13032基因组为模板以P33/P34引物对进行PCR扩增得到homG378E,以P35/P36引物对进行PCR扩增得到下游同源臂dn。以P29/P32引物对以up、PcspB为模板进行融合PCR,获得片段up-PcspB。以P29/P36引物对以up-PcspB、homG378E、dn为模板进行融合PCR获得全长片段up-PcspB-homG378E-dn。pK18mobsacB用BamHI/HindIII酶切。两者用无缝克隆试剂盒进行组装,转化Trans1 T1感受态细胞,获得重组质粒pK18mobsacB-PcspB-homG378E。
3、天冬氨酸氨基转移酶表达强化质粒pK18mobsacB-Psod-aspB的构建
以谷氨酸棒状杆菌ATCC 13032基因组为模板,以P103/P104引物对进行PCR扩增得到上游同源臂up,以P105/P106引物对进行PCR扩增得到启动子片段Psod,以P107/P108引物对进行PCR扩增得到下游同源臂dn。以P103/P108引物对以up、Psod、dn为模板进行融合PCR获得全长片段up-Psod-dn。pK18mobsacB用BamHI/HindIII酶切。两者用无缝克隆试剂盒进行组装,转化Trans1 T1感受态细胞,获得重组质粒pK18mobsacB-Psod-aspB。
4、苏氨酸合酶表达强化质粒pK18mobsacB-Psod-thrCg1a的构建
以ATCC13032基因组为模板,以P37/P38引物对进行PCR扩增得到上游同源臂up,以P39/P40引物对进行PCR扩增得到启动子片段Psod-thrCg1a,以P41/P42引物对进行PCR扩增得到下游同源臂dn。以P37/P42引物对以up、Psod-thrCV1M、dn为模板进行融合PCR获得全长片段up-Psod-thrCg1a-dn。pK18mobsacB用BamHI/HindIII酶切。两者用无缝克隆试剂盒进行组装,转化Trans1 T1感受态细胞,获得重组质粒pK18mobsacB-Psod-thrCg1a。
其中,g1a表示thrC基因(thrC野生型基因序列见SEQ ID NO:2)起始密码子的第1位碱基由g突变为a。5、2-甲酰-柠檬酸合酶1失活质粒pK18mobsacB-△prpC1的构建
以谷氨酸棒状杆菌ATCC 13032基因组为模板,以prpC1-UF/prpC1-UR引物对进行PCR扩增得到上游同源臂up,以prpC1-DF/prpC1-DR引物对进行PCR扩增得到下游同源臂dn。以prpC1-UF/prpC1-DR引物对以up、dn为模板进行融合PCR获得全长片段up-dn。pK18mobsacB用BamHI/HindIII酶切。两者用无缝克隆试剂盒进行组装,转化Trans1 T1感受态细胞,获得重组质粒pK18mobsacB-△prpC1。
6、NAD激酶表达强化质粒pK18mobsacB-Ptuf-ppnK的构建
以谷氨酸棒状杆菌ATCC 13032基因组为模板,以P109/P110引物对进行PCR扩增得到上游同源臂up,以P111/P112引物对进行PCR扩增得到启动子片段Ptuf,以P113/P114引物对进行PCR扩增得到下游同源臂dn。以P109/P114引物对以up、Ptuf、dn为模板进行融合PCR获得全长片段up-Ptuf-dn。pK18mobsacB用BamHI/HindIII酶切。两者用无缝克隆试剂盒进行组装,转化Trans1 T1感受态细胞,获得重组质粒pK18mobsacB-Ptuf-ppnK。
7、果糖-1,6-二磷酸酶表达强化质粒pK18mobsacB-Ptuf-fbp的构建
以谷氨酸棒状杆菌ATCC 13032基因组为模板,以P61/P62引物对进行PCR扩增得到上游同源臂up,以P63/P64引物对进行PCR扩增得到启动子片段Ptuf,以P65/P66引物对进行PCR扩增得到下游同源臂dn。以P61/P66引物对以up、Ptuf、dn为模板进行融合PCR获得全长片段up-Ptuf-dn。pK18mobsacB用BamHI/HindIII酶切。两者用无缝克隆试剂盒进行组装,转化Trans1 T1感受态细胞,获得重组质粒pK18mobsacB-Ptuf-fbp。
构建过程中所用引物如表1所示:
表1
注:加粗字体及下划线为引入相应点突变的引物。
实施例2基因组改造菌株的构建
1、2-甲酰-柠檬酸合酶1失活菌株的构建
按照谷棒经典方法(C.glutamicum Handbook,Charpter 23)制备谷氨酸棒状杆菌ATCC 13032感受态细胞。重组质粒pK18mobsacB-△prpC1以电穿孔方法转化该感受态细胞,并在含有15mg/L卡那霉素的选择培养基上筛选转化子,其中感兴趣的基因由于同源性被插入到染色体中。将筛得的转化子过夜培养于普通液体脑心浸液培养基中,培养温度为30℃,回转摇床220rpm振荡培养。此培养过程中,转化子发生第二次重组,通过基因交换将载体序列从基因组中除去。将培养物做连续梯度稀释(10-2连续稀释至10-4),稀释液涂布在含有10%蔗糖的普通固体脑心浸液培养基上,33℃静置培养48h。蔗糖培养基上长出的菌株在其基因组中不携带插入的载体序列。通过PCR扩增目的序列,核苷酸测序分析,获得目的突变菌株命名为SMCT089。
2、天冬氨酸激酶强化表达菌株的构建
按照谷棒经典方法(C.glutamicum Handbook,Charpter 23)制备ATCC13032感受态细胞。重组质粒pK18mobsacB-Psod-lysCg1a-T311I以电穿孔方法转化该感受态细胞,并在含有15mg/L卡那霉素的选择培养基上筛选转化子,其中感兴趣的基因由于同源性被插入到染色体中。将筛得的转化子过夜培养于普通液体脑心浸液培养基中,培养温度为30℃,回转摇床220rpm振荡培养。此培养过程中,转化子发生第二次重组,通过基因交换将载体序列从基因组中除去。将培养物做连续梯度稀释(10-2连续稀释至10-4),稀释液涂布在含有10%蔗糖的普通固体脑心浸液培养基上,33℃静置培养48h。蔗糖培养基上长出的菌株在其基因组中不携带插入的载体序列。通过PCR扩增目的序列,核苷酸测序分析,获得目的突变菌株命名为SMCT076。
3、高丝氨酸脱氢酶表达强化菌株的构建
按照谷棒经典方法(C.glutamicum Handbook,Charpter 23)制备SMCT076感受态细胞。重组质粒pK18mobsacB-PcspB-homG378E以电穿孔方法转化该感受态细胞,并在含有15mg/L卡那霉素的选择培养基上筛选转化子,其中感兴趣的基因由于同源性被插入到染色体中。将筛得的转化子过夜培养于普通液体脑心浸液培养基中,培养温度为30℃,回转摇床220rpm振荡培养。此培养过程中,转化子发生第二次重组,通过基因交换将载体序列从基因组中除去。将培养物做连续梯度稀释(10-2连续稀释至10-4),稀释液涂布在含有10%蔗糖的普通固体脑心浸液培养基上,33℃静置培养48h。蔗糖培养基上长出的菌株在其基因组中不携带插入的载体序列。通过PCR扩增目的序列,核苷酸测序分析,获得目的突变菌株命名为SMCT077。
4、苏氨酸合酶表达强化菌株的构建
按照谷棒经典方法(C.glutamicum Handbook,Charpter 23)制备SMCT077感受态细胞。重组质粒pK18mobsacB-Psod-thrCg1a以电穿孔方法转化该感受态细胞,并在含有15mg/L卡那霉素的选择培养基上筛选转化子,其中感兴趣的基因由于同源性被插入到染色体中。将筛得的转化子过夜培养于普通液体脑心浸液培养基中,培养温度为30℃,回转摇床220rpm振荡培养。此培养过程中,转化子发生第二次重组,通过基因交换将载体序列从基因组中除去。将培养物做连续梯度稀释(10-2连续稀释至10-4),稀释液涂布在含有10%蔗糖的普通固体脑心浸液培养基上,33℃静置培养48h。蔗糖培养基上长出的菌株在其基因组中不携带插入的载体序列。通过PCR扩增目的序列,核苷酸测序分析,获得目的突变菌株命名为SMCT078。
5、NAD激酶表达强化菌株的构建
按照谷棒经典方法(C.glutamicum Handbook,Charpter 23)制备SMCT077感受态细胞。重组质粒pK18mobsacB-Ptuf-ppnK以电穿孔方法转化该感受态细胞,并在含有15mg/L卡那霉素的选择培养基上筛选转化子,其中感兴趣的基因由于同源性被插入到染色体中。将筛得的转化子过夜培养于普通液体脑心浸液培养基中,培养温度为30℃,回转摇床220rpm振荡培养。此培养过程中,转化子发生第二次重组,通过基因交换将载体序列从基因组中除去。将培养物做连续梯度稀释(10-2连续稀释至10-4),稀释液涂布在含有10%蔗糖的普通固体脑心浸液培养基上,33℃静置培养48h。蔗糖培养基上长出的菌株在其基因组中不携带插入的载体序列。通过PCR扩增目的序列,核苷酸测序分析,获得目的突变菌株命名为SMCT079。
6、果糖-1,6-二磷酸酶表达强化菌株的构建
按照谷棒经典方法(C.glutamicum Handbook,Charpter 23)制备SMCT077、SMCT079感受态细胞。重组质粒pK18mobsacB-Ptuf-fbp以电穿孔方法转化该感受态细胞,并在含有15mg/L卡那霉素的选择培养基上筛选转化子,其中感兴趣的基因由于同源性被插入到染色体中。将筛得的转化子过夜培养于普通液体脑心浸液培养基中,培养温度为30℃,回转摇床220rpm振荡培养。此培养过程中,转化子发生第二次重组,通过基因交换将载体序列从基因组中除去。将培养物做连续梯度稀释(10-2连续稀释至10-4),稀释液涂布在含有10%蔗糖的普通固体脑心浸液培养基上,33℃静置培养48h。蔗糖培养基上长出的菌株在其基因组中不携带插入的载体序列。通过PCR扩增目的序列,核苷酸测序分析,获得目的突变菌株命名为SMCT080、SMCT081。
7、在SMCT081上进行天冬氨酸氨基转移酶和苏氨酸合酶的表达强化的改造
按照谷棒经典方法(C.glutamicum Handbook,Charpter 23)制备SMCT081感受态细胞。重组质粒pK18mobsacB-Psod-aspB以电穿孔方法转化该感受态细胞,并在含有15mg/L卡那霉素的选择培养基上筛选转化子,其中感兴趣的基因由于同源性被插入到染色体中。将筛得的转化子过夜培养于普通液体脑心浸液培养基中,培养温度为30℃,回转摇床220rpm振荡培养。此培养过程中,转化子发生第二次重组,通过基因交换将载体序列从基因组中除去。将培养物做连续梯度稀释(10-2连续稀释至10-4),稀释液涂布在含有10%蔗糖的普通固体脑心浸液培养基上,33℃静置培养48h。蔗糖培养基上长出的菌株在其基因组中不携带插入的载体序列。通过PCR扩增目的序列,核苷酸测序分析,获得目的突变菌株继续制备感受态细胞。重组质粒pK18mobsacB-Psod-thrCg1a以电穿孔方法转化该感受态细胞,并在含有15mg/L卡那霉素的选择培养基上筛选转化子,其中感兴趣的基因由于同源性被插入到染色体中。将筛得的转化子过夜培养于普通液体脑心浸液培养基中,培养温度为30℃,回转摇床220rpm振荡培养。此培养过程中,转化子发生第二次重组,通过基因交换将载体序列从基因组中除去。将培养物做连续梯度稀释(10-2连续稀释至10-4),稀释液涂布在含有10%蔗糖的普通固体脑心浸液培养基上,33℃静置培养48h。蔗糖培养基上长出的菌株在其基因组中不携带插入的载体序列。通过PCR扩增目的序列,核苷酸测序分析,获得目的突变菌株SMCT082。
8、2-甲酰-柠檬酸合酶1失活菌株的构建
按照谷棒经典方法(C.glutamicum Handbook,Charpter 23)制备SMCT077、SMCT078、SMCT079、SMCT080、SMCT081、SMCT082、感受态细胞。重组质粒pK18mobsacB-△prpC1以电穿孔方法转化该感受态细胞,并在含有15mg/L卡那霉素的选择培养基上筛选转化子,其中感兴趣的基因由于同源性被插入到染色体中。将筛得的转化子过夜培养于普通液体脑心浸液培养基中,培养温度为30℃,回转摇床220rpm振荡培养。此培养过程中,转化子发生第二次重组,通过基因交换将载体序列从基因组中除去。将培养物做连续梯度稀释(10-2连续稀释至10-4),稀释液涂布在含有10%蔗糖的普通固体脑心浸液培养基上,33℃静置培养48h。蔗糖培养基上长出的菌株在其基因组中不携带插入的载体序列。通过PCR扩增目的序列,核苷酸测序分析,获得目的突变菌株命名为SMCT083、SMCT084、SMCT085、SMCT086、SMCT087、SMCT088。
获得的菌株如表2所示:
表2
实施例3构建菌株摇瓶验证
1.培养基
种子活化培养基:BHI 3.7%,琼脂2%,pH7。
种子培养基:蛋白胨5/L,酵母抽提物5g/L,氯化钠10g/L,硫酸铵16g/L,尿素8g/L,磷酸二氢钾10.4g/L,磷酸氢二钾21.4g/L,生物素5mg/L,硫酸镁3g/L。葡萄糖50g/L,pH7.2。
发酵培养基:玉米浆50mL/L,葡萄糖30g/L,硫酸铵4g/L,MOPS 30g/L,磷酸二氢钾10g/L,尿素20g/L,生物素10mg/L,硫酸镁6g/L,硫酸亚铁1g/L,VB1·HCl 40mg/L,泛酸钙50mg/L,烟酰胺40mg/L,硫酸锰1g/L,硫酸锌20mg/L,硫酸铜20mg/L,pH 7.2。
2.工程菌摇瓶发酵生产L-苏氨酸
(1)种子培养:挑SMCT076、SMCT077、SMCT078、SMCT079、SMCT080、SMCT081、SMCT082、SMCT083、SMCT084、SMCT085、SMCT086、SMCT088斜面种子1环接至装有20mL种子培养基的500mL三角瓶中,30℃、220r/min振荡培养16h。
(2)发酵培养:将2mL种子液接种至装有20mL发酵培养基的500mL三角瓶中,33℃、220r/min振荡培养24h。
(3)取1mL发酵液离心(12000rpm,2min),收集上清液,用HPLC检测工程菌与对照菌发酵液中的L-苏氨酸。
谷氨酸棒状杆菌生产苏氨酸能力的比较见表3:
表3
菌株编号 | OD562 | 苏氨酸(g/L) | 菌株编号 | OD562 | 苏氨酸(g/L) |
ATCC13032 | 25 | — | SMCT089 | 25 | 0.2 |
SMCT076 | 23 | 1.2 | — | — | — |
SMCT077 | 23 | 2.4 | SMCT083 | 23 | 3.3 |
SMCT078 | 24 | 3.0 | SMCT084 | 24 | 4.1 |
SMCT079 | 24 | 3.3 | SMCT085 | 24 | 4.5 |
SMCT080 | 23 | 3.5 | SMCT086 | 23 | 5.0 |
SMCT081 | 22 | 8.0 | SMCT087 | 22 | 9.2 |
SMCT082 | 22 | 10.2 | SMCT088 | 22 | 12.5 |
由表3可以看出,在野生菌株ATCC13032的基础上进行天冬氨酸激酶的改造后菌株苏氨酸的产量初步的积累,随着苏氨酸合成路径中的酶(高丝氨酸脱氢酶、天冬氨酸氨基转移酶、苏氨酸合酶)表达的强化,苏氨酸的产量有了进一步的提升,随后对NAD激酶和果糖1,6-二磷酸酶表达的强化,菌株还原力的供应进一步加强,这有利于苏氨酸产量的提升。
为了探究2-甲酰-柠檬酸合酶1对苏氨酸产量的影响,在苏氨酸生产菌的基础上,进一步失活2-甲酰-柠檬酸合酶1,由表3可以看出所有2-甲酰-柠檬酸合酶1的改造菌均的苏氨酸产量均有不同程度的提升,其中最高较对照菌株提高42%。由此可见2-甲酰-柠檬酸合酶1失活有利于菌株苏氨酸产量的提升。
以上仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以对之做一些改进和修饰,比如表达强化可以采用强启动子、RBS序列的改变、起始密码子的改变、氨基酸序列的改变造成活性增强等,表达失活包括蛋白活性的失活及弱化等,这些改进和修饰均属于本发明要求保护的范围。
序列表
<110> 廊坊梅花生物技术开发有限公司
<120> 产苏氨酸工程菌的构建方法
<130> KHP211124127.1
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1266
<212> DNA
<213> 谷氨酸棒状杆菌(Corynebacterium glutamicum)
<400> 1
gtggccctgg tcgtacagaa atatggcggt tcctcgcttg agagtgcgga acgcattaga 60
aacgtcgctg aacggatcgt tgccaccaag aaggctggaa atgatgtcgt ggttgtctgc 120
tccgcaatgg gagacaccac ggatgaactt ctagaacttg cagcggcagt gaatcccgtt 180
ccgccagctc gtgaaatgga tatgctcctg actgctggtg agcgtatttc taacgctctc 240
gtcgccatgg ctattgagtc ccttggcgca gaagcccaat ctttcacggg ctctcaggct 300
ggtgtgctca ccaccgagcg ccacggaaac gcacgcattg ttgatgtcac tccaggtcgt 360
gtgcgtgaag cactcgatga gggcaagatc tgcattgttg ctggtttcca gggtgttaat 420
aaagaaaccc gcgatgtcac cacgttgggt cgtggtggtt ctgacaccac tgcagttgcg 480
ttggcagctg ctttgaacgc tgatgtgtgt gagatttact cggacgttga cggtgtgtat 540
accgctgacc cgcgcatcgt tcctaatgca cagaagctgg aaaagctcag cttcgaagaa 600
atgctggaac ttgctgctgt tggctccaag attttggtgc tgcgcagtgt tgaatacgct 660
cgtgcattca atgtgccact tcgcgtacgc tcgtcttata gtaatgatcc cggcactttg 720
attgccggct ctatggagga tattcctgtg gaagaagcag tccttaccgg tgtcgcaacc 780
gacaagtccg aagccaaagt aaccgttctg ggtatttccg ataagccagg cgaggctgcg 840
aaggttttcc gtgcgttggc tgatgcagaa atcaacattg acatggttct gcagaacgtc 900
tcttctgtag aagacggcac caccgacatc accttcacct gccctcgttc cgacggccgc 960
cgcgcgatgg agatcttgaa gaagcttcag gttcagggca actggaccaa tgtgctttac 1020
gacgaccagg tcggcaaagt ctccctcgtg ggtgctggca tgaagtctca cccaggtgtt 1080
accgcagagt tcatggaagc tctgcgcgat gtcaacgtga acatcgaatt gatttccacc 1140
tctgagattc gtatttccgt gctgatccgt gaagatgatc tggatgctgc tgcacgtgca 1200
ttgcatgagc agttccagct gggcggcgaa gacgaagccg tcgtttatgc aggcaccgga 1260
cgctaa 1266
<210> 2
<211> 1446
<212> DNA
<213> 谷氨酸棒状杆菌(Corynebacterium glutamicum)
<400> 2
gtggactaca tttcgacgcg tgatgccagc cgtacccctg cccgcttcag tgatattttg 60
ctgggcggtc tagcaccaga cggcggcctg tacctgcctg caacctaccc tcaactagat 120
gatgcccagc tgagtaaatg gcgtgaggta ttagccaacg aaggatacgc agctttggct 180
gctgaagtta tctccctgtt tgttgatgac atcccagtag aagacatcaa ggcgatcacc 240
gcacgcgcct acacctaccc gaagttcaac agcgaagaca tcgttcctgt caccgaactc 300
gaggacaaca tttacctggg ccacctttcc gaaggcccaa ccgctgcatt caaagacatg 360
gccatgcagc tgctcggcga acttttcgaa tacgagcttc gccgccgcaa cgaaaccatc 420
aacatcctgg gcgctacctc tggcgatacc ggctcctctg cggaatacgc catgcgcggc 480
cgcgagggaa tccgcgtatt catgctgacc ccagctggcc gcatgacccc attccagcaa 540
gcacagatgt ttggccttga cgatccaaac atcttcaaca tcgccctcga cggcgttttc 600
gacgattgcc aagacgtagt caaggctgtc tccgccgacg cagaattcaa aaaagacaac 660
cgcatcggtg ccgtgaactc catcaactgg gcacgcctta tggcacaggt tgtgtactac 720
gtttcctcat ggatccgcac cacaaccagc aatgaccaaa aggtcagctt ctccgtacca 780
accggcaact tcggtgacat ttgcgcaggc cacatcgccc gccaaatggg acttcccatc 840
gatcgcctca tcgtggccac caacgaaaac gatgtgctcg acgagttctt ccgtaccggc 900
gactaccgag tccgcagctc cgcagacacc cacgagacct cctcaccttc gatggatatc 960
tcccgcgcct ccaacttcga gcgtttcatc ttcgacctgc tcggccgcga cgccacccgc 1020
gtcaacgatc tatttggtac ccaggttcgc caaggcggat tctcactggc tgatgacgcc 1080
aactttgaga aggctgcagc agaatacggt ttcgcctccg gacgatccac ccatgctgac 1140
cgtgtggcaa ccatcgctga cgtgcattcc cgcctcgacg tactaatcga tccccacacc 1200
gccgacggcg ttcacgtggc acgccagtgg agggacgagg tcaacacccc aatcatcgtc 1260
ctagaaactg cactcccagt gaaatttgcc gacaccatcg tcgaagcaat tggtgaagca 1320
cctcaaactc cagagcgttt cgccgcgatc atggatgctc cattcaaggt ttccgaccta 1380
ccaaacgaca ccgatgcagt taagcagtac atagtcgatg cgattgcaaa cacttccgtg 1440
aagtaa 1446
Claims (9)
1.一种修饰的棒状杆菌属微生物,其特征在于,所述微生物相比于未修饰的微生物,其2-甲酰-柠檬酸合酶1的活性降低或丧失,且所述微生物相比于未修饰的微生物具有增强的苏氨酸生产能力。
2.根据权利要求1所述的微生物,其特征在于,所述微生物体内2-甲酰-柠檬酸合酶1的活性降低或丧失是通过降低编码2-甲酰-柠檬酸合酶1基因的表达或敲除内源的编码2-甲酰-柠檬酸合酶1的基因来实现的。
3.根据权利要求2所述的微生物,其特征在于,采用诱变、定点突变或同源重组的方法来降低编码2-甲酰-柠檬酸合酶1基因的表达或敲除内源的编码2-甲酰-柠檬酸合酶1的基因。
4.根据权利要求1所述的微生物,其特征在于,所述微生物与未修饰的微生物相比,其体内苏氨酸合成途径相关的酶的活性增强;
其中,所述与苏氨酸合成途径相关的酶选自天冬氨酸氨基转移酶、天冬氨酸激酶、高丝氨酸脱氢酶、苏氨酸合酶、NAD激酶、果糖-1,6-二磷酸酶2中的至少一种。
5.根据权利要求4所述的微生物,其特征在于,所述微生物为如下①~⑤中的任一种:
①2-甲酰-柠檬酸合酶1活性降低或丧失且天冬氨酸激酶和/或高丝氨酸脱氢酶活性增强的微生物;
②2-甲酰-柠檬酸合酶1活性降低或丧失且天冬氨酸激酶、高丝氨酸脱氢酶和/或苏氨酸合酶活性增强的微生物;
③2-甲酰-柠檬酸合酶1活性降低或丧失且天冬氨酸激酶、高丝氨酸脱氢酶和/或NAD激酶活性增强的微生物;
④2-甲酰-柠檬酸合酶1活性降低或丧失且天冬氨酸激酶、高丝氨酸脱氢酶、NAD激酶和/或果糖-1,6-二磷酸酶2活性增强的微生物;
⑤2-甲酰-柠檬酸合酶1活性降低或丧失且天冬氨酸氨基转移酶、天冬氨酸激酶、高丝氨酸脱氢酶、苏氨酸合酶、NAD激酶和果糖-1,6-二磷酸酶2活性增强的微生物。
6.根据权利要求4所述的微生物,其特征在于,所述微生物体内苏氨酸合成途径相关的酶的活性的增强是由选自以下1)~6),或任选的组合实现的:
1)通过导入具有所述酶的编码基因的质粒而增强;
2)通过增加染色体上所述酶的编码基因的拷贝数而增强;
3)通过改变染色体上所述酶的编码基因的启动子序列而增强;
4)通过将强启动子与所述酶的编码基因可操作地连接而增强;
5)通过对酶的氨基酸序列进行改变而增强;
6)通过对编码酶的核苷酸序列进行改变而增强。
7.根据权利要求1-5任一项所述的微生物,其特征在于,所述微生物为谷氨酸棒状杆菌(Corynebacterium glutamicum)。
8.产苏氨酸工程菌的构建方法,其特征在于,所述方法包括:
A、弱化具有氨基酸生产能力的棒杆菌中编码2-甲酰-柠檬酸合酶1的基因,获得基因弱化菌株;所述弱化包括敲除或降低2-甲酰-柠檬酸合酶1编码基因的表达;和/或
B、增强步骤A基因弱化菌株中与苏氨酸合成途径相关的酶,获得酶活增强菌株;
所述增强的途径选自以下1)~5),或任选的组合:
1)通过导入具有所述酶的编码基因的质粒而增强;
2)通过增加染色体上所述酶的编码基因的拷贝数而增强;
3)通过改变染色体上所述酶的编码基因的启动子序列而增强;
4)通过将强启动子与所述酶的编码基因可操作地连接而增强;
5)通过对酶的氨基酸序列进行改变而增强;
其中,所述与苏氨酸合成途径相关的酶选自天冬氨酸氨基转移酶、天冬氨酸激酶、高丝氨酸脱氢酶、苏氨酸合酶、NAD激酶、果糖-1,6-二磷酸酶2中的至少一种。
9.一种生产苏氨酸的方法,其特征在于,所述方法包括如下步骤:
a)培养权利要求1-7任一项所述的微生物,以获得所述微生物的培养物;
b)从步骤a)中获得的所述培养物中收集所产生的苏氨酸。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210096134.2A CN116536226A (zh) | 2022-01-26 | 2022-01-26 | 产苏氨酸工程菌的构建方法 |
PCT/CN2022/143105 WO2023142861A1 (zh) | 2022-01-26 | 2022-12-29 | 产苏氨酸工程菌的构建方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210096134.2A CN116536226A (zh) | 2022-01-26 | 2022-01-26 | 产苏氨酸工程菌的构建方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116536226A true CN116536226A (zh) | 2023-08-04 |
Family
ID=87454742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210096134.2A Pending CN116536226A (zh) | 2022-01-26 | 2022-01-26 | 产苏氨酸工程菌的构建方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN116536226A (zh) |
WO (1) | WO2023142861A1 (zh) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102009030342A1 (de) * | 2009-06-25 | 2010-12-30 | Evonik Degussa Gmbh | Verfahren zur fermentativen Herstellung von organisch chemischen Verbindungen |
JP5719434B2 (ja) * | 2010-06-15 | 2015-05-20 | パク グアン インダストリアル カンパニー リミテッドPaik Kwang Industrial Co., Ltd. | 微生物を用いたアスパラギン酸系アミノ酸の生産方法 |
US10428359B2 (en) * | 2016-10-03 | 2019-10-01 | Ajinomoto Co, Inc. | Method for producing L-amino acid |
CN109706106B (zh) * | 2019-01-28 | 2021-01-29 | 江南大学 | 一种强化脂肪酸降解和乙醛酸循环提高苏氨酸产量的方法 |
CN113322218B (zh) * | 2020-02-28 | 2022-11-22 | 廊坊梅花生物技术开发有限公司 | 重组谷氨酸棒杆菌及生产l-苏氨酸的方法 |
-
2022
- 2022-01-26 CN CN202210096134.2A patent/CN116536226A/zh active Pending
- 2022-12-29 WO PCT/CN2022/143105 patent/WO2023142861A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2023142861A9 (zh) | 2023-09-21 |
WO2023142861A1 (zh) | 2023-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113322218B (zh) | 重组谷氨酸棒杆菌及生产l-苏氨酸的方法 | |
KR101483344B1 (ko) | L-라이신 생산능을 갖는 미생물을 이용하여 l-라이신을 생산하는 방법 | |
KR101285945B1 (ko) | L-라이신 생산능이 향상된 코리네박테리움 속 미생물 및 이를 이용한 l-라이신의 제조방법 | |
KR101429815B1 (ko) | GntK 활성 조절을 통해 L-쓰레오닌 생산능이 향상된 코리네박테리움 속 미생물 및 이를 이용한 L-쓰레오닌 생산 방법 | |
CN116536226A (zh) | 产苏氨酸工程菌的构建方法 | |
CN116555134A (zh) | 产苏氨酸菌株的构建方法 | |
WO2023151407A1 (zh) | 苏氨酸生产菌株的构建方法 | |
CN116622599A (zh) | 高产苏氨酸菌株的构建方法 | |
CN116555135A (zh) | 高产苏氨酸基因工程菌的构建方法 | |
CN116622597A (zh) | 高产苏氨酸工程菌的构建方法 | |
CN116622596A (zh) | 一种修饰的棒状杆菌属微生物及其构建方法与在生产苏氨酸中的应用 | |
CN116536227A (zh) | 一种生产苏氨酸的修饰的棒状杆菌属微生物及其构建方法与应用 | |
WO2023151406A1 (zh) | 苏氨酸生产菌株的构建方法 | |
CN116606785A (zh) | 一种修饰的棒状杆菌属微生物及其应用与构建方法 | |
CN116606786A (zh) | 一种生产苏氨酸的重组微生物及其构建方法和应用 | |
CN116555136A (zh) | 一种修饰的棒状杆菌属微生物及其构建方法与应用 | |
CN116555130A (zh) | 产苏氨酸基因工程菌的构建方法 | |
CN116555251A (zh) | 一种生产苏氨酸的重组微生物及其应用 | |
CN116555132A (zh) | 一种修饰的棒状杆菌属微生物及其生产苏氨酸的应用和构建方法 | |
CN116536310A (zh) | 启动子、产苏氨酸重组微生物及其应用 | |
CN116555131A (zh) | 一种重组微生物及其构建方法和应用 | |
KR102377745B1 (ko) | 신규 프로모터 및 이의 용도 | |
CN116555365A (zh) | 修饰的棒状杆菌属微生物及其构建方法和应用 | |
CN116555137A (zh) | 一种苏氨酸生产菌株及其应用 | |
CN115029289A (zh) | 高产l-苏氨酸的基因工程菌及其构建方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |